Hunter Firment

3 weeks ago | healio.com | Hunter Firment

The FDA approved fitusiran (Qfitlia, Sanofi) for routine prophylaxis for prevention or reduction in bleeding episodes in patients with hemophilia A or hemophilia B who are above 12 years old, according to a press release. Fitusiran (Qfitlia, Sanofi) does not replace the missing clotting factor. However, it does reduce antithrombin levels, which leads to an increase in thrombin, an enzyme critical for blood clotting, the FDA said in the release.

3 weeks ago | healio.com | Hunter Firment

Receive an email when new articles are posted onPlease provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. • Patients with a higher BMI and longer operative time had an increased risk for wound complications following THA. • Negative pressure wound therapy did not mitigate risk for wound complications.

4 weeks ago | healio.com | Hunter Firment

Receive an email when new articles are posted onPlease provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. • Patients with OA who had difficulties with social determinants of health less likely underwent TJA. • Difficulties with social determinants of health were an independent negative predictor for TJA.

4 weeks ago | healio.com | Hunter Firment

Receive an email when new articles are posted onPlease provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. • NSAIDs may reduce manipulation under anesthesia after TKA. • For patients who cannot take anti-inflammatory drugs, corticosteroids may be an effective alternative.

1 month ago | healio.com | Hunter Firment

Receive an email when new articles are posted onPlease provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. • A novel synthetic bone graft showed noninferiority to autograft in posterolateral spinal fusion. • The synthetic graft also diminished the effects of smoking on surgical outcomes.